24 June 2015
Training people to focus better when distracted can help them worry less, according to a study published today.
The report, published today in journal Clinical Psychological Science, reports on results of two studies involving people with a high tendency to worry.
Professor Elaine Fox, from Oxford’s Department of Experimental Psychology said: ‘In the first study, we conditioned high and low worriers to fear an angry face. They were then asked to complete a task that required them to concentrate, with the face appearing as a distraction. We found that high worriers found this much more difficult – that is, they were more easily distracted compared to low worriers.
‘We then assessed how well each person could suppress worries. After a period of preparation where they discussed what was worrying them most, they sat for five minutes trying not to think about that topic. High worriers had intrusive thoughts about their worry topic more often than low worriers. The key finding was that those who found it more difficult to concentrate also had more problems controlling their worrying thoughts.’
In the second study, a different group of high worriers went through the same stages as in the first, but they also had a series of five training sessions over three days. Half the participants received sham cognitive training while half received active cognitive training designed to improve their attentional control – ability to deal with distraction.
After the training sessions they were retested on both the original concentration task and their ability to control worry.
Dr Alan Yates, Senior Lecturer in Psychology at University Campus Oldham (UCO), said: ‘When we then asked the participants to sit and not think about their worry topic, we found that those who had received active cognitive training were slightly more likely to have fewer intrusive worry thoughts than before. We saw no change in the sham training group.’
The team say that their results are a confirmation of earlier reports of a link between attentional control (the ability to concentrate) and the ability to suppress repetitive negative thoughts. The tests also indicate that it could be possible to improve people’s ability to control negative thoughts by training them to increase their ability to concentrate.
Professor Fox said: ‘These tests were on relatively small groups and a lot more research is needed to work out the best training design for effective treatment. In the end, attentional control training is likely to be effective when used alongside other support and treatment.’
For more information please contact the University of Oxford news & information office on +44 (0)1865 280530 or firstname.lastname@example.org or University Campus Oldham press office on +44 (0)161 785 5489 or email@example.com.
Notes to Editors:
University Campus Oldham is committed to providing employment, training and educational opportunities for its communities and aims to help every student reach their full potential. UCO offers a learning environment with industry standard facilities and has close links with many local, regional and national employers. These relationships enrich and broaden the courses that UCO offers as well as preparing students for progression into employment and higher education. For more information please visit www.uco.oldham.ac.uk or call 0161 344 8800.
Oxford University’s Medical Sciences Division is one of the largest biomedical research centres in Europe, with over 2,500 people involved in research and more than 2,800 students. The University is rated the best in the world for medicine, and it is home to the UK’s top-ranked medical school.
From the genetic and molecular basis of disease to the latest advances in neuroscience, Oxford is at the forefront of medical research. It has one of the largest clinical trial portfolios in the UK and great expertise in taking discoveries from the lab into the clinic. Partnerships with the local NHS Trusts enable patients to benefit from close links between medical research and healthcare delivery.
A great strength of Oxford medicine is its long-standing network of clinical research units in Asia and Africa, enabling world-leading research on the most pressing global health challenges such as malaria, TB, HIV/AIDS and flu. Oxford is also renowned for its large-scale studies which examine the role of factors such as smoking, alcohol and diet on cancer, heart disease and other conditions.